Joseph Lee, MD
President and Chief Executive Officer at Hazelden Betty Ford Foundation
Center City, Minnesota, USA
As CEO of the largest U.S. nonprofit behavioral health provider, he sets referral, payer, and partnership standards that any rollup platform will be measured against.
Background
Joseph Lee, MD is President and CEO of the Hazelden Betty Ford Foundation, the largest nonprofit provider of addiction and mental health treatment in the U.S., a post he has held since June 2021. A triple-board-certified physician trained in adult psychiatry at Duke and child/adolescent psychiatry at Johns Hopkins, he spent over a decade as medical director of Hazelden's Youth Continuum before becoming the organization's first physician-CEO, first non-white leader, and youngest CEO in its history. He is a nationally recognized voice on youth addiction and family recovery, author of 'Recovering My Kid,' and chairs the board of the Saint Paul & Minnesota Foundation.
Notable deals
- 2012
- 2021
- 2025
- 2025
Call-prep brief
Background
- MD, triple-board certified (general psychiatry, child/adolescent psychiatry, addiction medicine); Duke residency, Johns Hopkins fellowship, University of Oklahoma med school.
- Joined Hazelden Betty Ford in 2010 as medical director of the Youth Continuum; named President & CEO in Feb 2021, effective June 2021 — the org's first physician-CEO, first non-white leader, and youngest CEO in its 72-year history.
- Also President of the Hazelden Betty Ford Graduate School of Addiction Studies and Board Chair of the Saint Paul & Minnesota Foundation.
Current Focus
- Expanding access via payer partnerships (2025 HealthPartners Medicaid IOP deal) and affinity-group partnerships (Sigma Chi Wayfinder portal, Sept 2025).
- Vocal on youth/family addiction, emerging drug trends (fentanyl, vaping), and integrating mental health with SUD treatment.
What He Cares About
- Nonprofit mission integrity and equitable access — has spoken publicly about pandemic-driven gaps in care for underserved populations.
- Clinical rigor and evidence-based, family-centered treatment models over pure volume growth.
Potential Sensitivities
- Leads a nonprofit; likely wary of framing that reads as "consolidation for profit" rather than access expansion.
- Labor relations (nursing staff actions at Hazelden Betty Ford) could be a sensitive topic.
- As a public thought leader, mission and reputational alignment likely outweigh pure deal economics for him.
Questions to Ask
- How is Hazelden Betty Ford weighing partnerships vs. outright M&A to expand capacity in underserved markets?
- What criteria make a payer or affinity-group partnership (like HealthPartners or Sigma Chi) work operationally and clinically?
- Where does he see the biggest capacity gaps in youth/family addiction treatment that a well-capitalized platform could responsibly fill?
Outreach draft
Linked companies
- Hazelden Betty Ford FoundationPresident and CEO leading the organization since 2021
- HealthPartnersPartnered to expand Medicaid addiction and mental health access
- Saint Paul & Minnesota FoundationServes as board chair of this community foundation
- Sigma Chi International FraternityPartnered on member behavioral health Wayfinder portal
Sources
- Structured dataOtherspmcf.org/team/joseph-lee-m-d
- Page titleOthertcbmag.com/hazelden-betty-ford-foundation-names-dr-joseph-lee-its-next-ceo
- Name + firmPrimaryhazelden.org/store/item/181105?Recovering-My-Kid=
- Structured dataPrimaryhazeldenbettyford.org/about/leadership/joseph-lee
- Name + firmPrimaryhazeldenbettyford.org/newsroom/press-release/new-sigma-chi-partnership
- Name + firmOtherhealthpartners.com/about/newsroom/press-releases/new-partnership-expands-hazelden-betty-ford-foundation-services-to-hp-medicaid-plan-members